Purchase Order 1232SD18P0404
- Not listed
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- Genscript USA Inc., a biotechnology company based in New Jersey, was awarded a $6,463.55 firm fixed-price purchase order contract by the USDA's Northeast Area to generate an IFNAR1 knockout HEK293 cell line. This contract is not set aside for any specific business category. Genscript has a significant blanket purchase agreement (BPA) worth up to $1.5 million with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in New Jersey. The $7,402.06 firm fixed-price purchase order is for the preparation of plasmid DNA samples to support biomedical research. Genscript has received numerous prime and subcontract awards from NIAID, the Centers for Disease Control and Prevention (CDC), the Food and Drug...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $9,062.13 firm fixed-price purchase order is for plasmid and recombinant protein expression services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has a history of...
- The U.S. Department of Agriculture (USDA) awarded a $6,701.14 firm fixed-price purchase order to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of antibodies against avian herpesvirus antigens, which supports USDA's animal disease monitoring and research efforts. This award is part of a larger $1.5 million blanket purchase agreement (BPA) between Genscript and USDA's Animal and Plant Health Inspection Service (APHIS) to provide...
- This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration) as well as the Department of Agriculture, to provide a range of molecular biology products and services in support of biomedical research and public health initiatives. This includes synthesizing genes, developing antibodies, and producing other biological materials for applications like vaccine development, therapeutic research, and diagnostic assay creation - often in response to emerging infectious disease threats. The current contract appears to be part of a larger blanket purchase agreement Genscript holds with the USDA's Animal and Plant Health Inspection Service, valued at up to $1.5 million through 2024, to supply SARS-CoV-2 surrogate virus neutralization test kits and reagents in support of the agency's animal disease monitoring and research efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 6/26/18 |